Cargando…
Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination
PURPOSE: The primary objective of the current study is to determine whether bariatric surgery reversed the negative impact of obesity on the serological response after the COVID-19 vaccination. This objective is achieved in two steps: (a) quantifying the negative impact of obesity on the serological...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050480/ https://www.ncbi.nlm.nih.gov/pubmed/35486149 http://dx.doi.org/10.1007/s00423-022-02516-6 |
_version_ | 1784696375790796800 |
---|---|
author | Hany, Mohamed Torensma, Bart Abouelnasr, Anwar Ashraf Zidan, Ahmed Ibrahim, Mohamed Agayby, Ann Samy Shafiq Hesham, Mohamed Elsheredy, Amel Abu-Sheasha, Ghada Ahmed |
author_facet | Hany, Mohamed Torensma, Bart Abouelnasr, Anwar Ashraf Zidan, Ahmed Ibrahim, Mohamed Agayby, Ann Samy Shafiq Hesham, Mohamed Elsheredy, Amel Abu-Sheasha, Ghada Ahmed |
author_sort | Hany, Mohamed |
collection | PubMed |
description | PURPOSE: The primary objective of the current study is to determine whether bariatric surgery reversed the negative impact of obesity on the serological response after the COVID-19 vaccination. This objective is achieved in two steps: (a) quantifying the negative impact of obesity on the serological response after COVID-19 vaccination if it is present, and (b) testing whether bariatric surgery reversed this impact. The secondary objective was to monitor the occurrence of adverse events. METHODS: This is a prospective cohort study between May 2021 and August 2021 on the strength of serological response after COVID-19 vaccination. Patients were classified into three groups. Group A (controls with normal or overweight), Group B (bariatric patients pre-operative), and Group C (bariatric patients post-operative). Quantitative antibodies against SARS‑CoV‑2 RBD with a strong neutralizing capacity were quantified from sera after at least 2 weeks post-vaccination. RESULTS: Of the 276 participants, Group A had n = 73, Group B had n = 126, and Group C had n = 77 patients. Overall, a strongly positive vaccine serological response was observed among 86% in group A, 63% in Group B, and 88% in Group C. Group C showed 5.33 times [95% CI 2.15 to 13.18] higher immune response than group B. Mild to moderate adverse events occurred in 30.1% [95% CI 24.7 to 35.9] of the study samples. Adverse events with the whole virus, mRNA, and vector vaccines occurred in 25%, 28%, and 37%, respectively. CONCLUSION: Vaccinating and bariatric surgery are safe and effective treatments in the serological response in patients who suffer from obesity. |
format | Online Article Text |
id | pubmed-9050480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-90504802022-04-29 Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination Hany, Mohamed Torensma, Bart Abouelnasr, Anwar Ashraf Zidan, Ahmed Ibrahim, Mohamed Agayby, Ann Samy Shafiq Hesham, Mohamed Elsheredy, Amel Abu-Sheasha, Ghada Ahmed Langenbecks Arch Surg Original Article PURPOSE: The primary objective of the current study is to determine whether bariatric surgery reversed the negative impact of obesity on the serological response after the COVID-19 vaccination. This objective is achieved in two steps: (a) quantifying the negative impact of obesity on the serological response after COVID-19 vaccination if it is present, and (b) testing whether bariatric surgery reversed this impact. The secondary objective was to monitor the occurrence of adverse events. METHODS: This is a prospective cohort study between May 2021 and August 2021 on the strength of serological response after COVID-19 vaccination. Patients were classified into three groups. Group A (controls with normal or overweight), Group B (bariatric patients pre-operative), and Group C (bariatric patients post-operative). Quantitative antibodies against SARS‑CoV‑2 RBD with a strong neutralizing capacity were quantified from sera after at least 2 weeks post-vaccination. RESULTS: Of the 276 participants, Group A had n = 73, Group B had n = 126, and Group C had n = 77 patients. Overall, a strongly positive vaccine serological response was observed among 86% in group A, 63% in Group B, and 88% in Group C. Group C showed 5.33 times [95% CI 2.15 to 13.18] higher immune response than group B. Mild to moderate adverse events occurred in 30.1% [95% CI 24.7 to 35.9] of the study samples. Adverse events with the whole virus, mRNA, and vector vaccines occurred in 25%, 28%, and 37%, respectively. CONCLUSION: Vaccinating and bariatric surgery are safe and effective treatments in the serological response in patients who suffer from obesity. Springer Berlin Heidelberg 2022-04-29 2022 /pmc/articles/PMC9050480/ /pubmed/35486149 http://dx.doi.org/10.1007/s00423-022-02516-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Hany, Mohamed Torensma, Bart Abouelnasr, Anwar Ashraf Zidan, Ahmed Ibrahim, Mohamed Agayby, Ann Samy Shafiq Hesham, Mohamed Elsheredy, Amel Abu-Sheasha, Ghada Ahmed Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination |
title | Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination |
title_full | Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination |
title_fullStr | Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination |
title_full_unstemmed | Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination |
title_short | Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination |
title_sort | impact of bariatric surgery on the effectiveness of serological response after covid-19 vaccination |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050480/ https://www.ncbi.nlm.nih.gov/pubmed/35486149 http://dx.doi.org/10.1007/s00423-022-02516-6 |
work_keys_str_mv | AT hanymohamed impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT torensmabart impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT abouelnasranwarashraf impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT zidanahmed impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT ibrahimmohamed impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT agaybyannsamyshafiq impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT heshammohamed impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT elsheredyamel impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination AT abusheashaghadaahmed impactofbariatricsurgeryontheeffectivenessofserologicalresponseaftercovid19vaccination |